Furthermore, in a model proposed by Yurkovetsky et al. [42], a multibiomarker panel with CA125, HE4, CEA, and VCAM-1 was highly recommended for early detection of ovarian cancer with 86% sensitivity and 98% specificity. This evidence concerns the gene WFDC2 and ovarian cancer.